BTN2A1-BRAF fusion may be a novel mechanism of resistance to osimertinib in lung adenocarcinoma: a case report
@article{TCR71377, author = {Wei-Min Kong and Yong-Jun Guo and Jie Ma and Chao Shi}, title = {BTN2A1-BRAF fusion may be a novel mechanism of resistance to osimertinib in lung adenocarcinoma: a case report}, journal = {Translational Cancer Research}, volume = {12}, number = {1}, year = {2023}, keywords = {}, abstract = {}, issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/71377} }